|
市場調査レポート
商品コード
1086915
慢性腎臓病(CKD)の疫学分析および予測:2021~2031年Chronic Kidney Disease Epidemiology Analysis and Forecast, 2021-2031 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。 |
慢性腎臓病(CKD)の疫学分析および予測:2021~2031年 |
出版日: 2022年05月11日
発行: GlobalData
ページ情報: 英文 36 Pages
納期: 即納可能
|
世界の慢性腎臓病(CKD)の主要7市場(7MM:米国、フランス、ドイツ、イタリア、スペイン、英国、日本)において、CKDの総有病者数が2021年の1億3,48万5,844例から、2031年の1億1,435万1,930例へと増加し、予測期間中のAGRは1.05%になると予測されています。
当レポートでは、世界の慢性腎臓病(CKD)市場について調査分析し、7MMにおけるCKDのリスク要因、併存疾患、世界および過去の疫学動向をはじめ、CKDの疫学的予測に関する情報を提供しています。
Chronic kidney disease (CKD) (ICD-10 = N18) is a condition characterized by a gradual loss of kidney function over time. This leads to the accumulation of excess fluid and waste in the body. In the early stages, CKD is a largely asymptomatic condition. As the disease progresses, the symptoms worsen and eventually lead to kidney failure (Centers for Disease Control and Prevention, 2022). Advanced chronic kidney disease can cause dangerous levels of fluid, electrolytes, and wastes to build up in the body (Mayo Clinic, 2021). The glomerular filtration rate (GFR), a key measure of kidney function, is determined by the amount of creatinine in the blood, and the Kidney Disease Improving Global Outcomes (KDIGO) classification system is considered to be the standard for GFR measurement and diagnosis of CKD (Levin et al., 2013). This report provides an overview of the risk factors, comorbidities, and the global and historical epidemiological trends for CKD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
The report includes a 10-year epidemiology forecast for the total prevalent cases and diagnosed prevalent cases of CKD. The total and diagnosed prevalent cases of CKD are further segmented by age (18 years and older), sex, and stage (stage I, stage II, stage IIIa, stage IIIb, stage IV, and stage V) in these markets. Diagnosed prevalent cases of CKD are further segmented by dialysis-dependent (including both hemodialysis and peritoneal dialysis) and non-dialysis dependent. The following data describes epidemiology of CKD. In the 7MM, GlobalData epidemiologists forecast an increase in the total prevalent cases of CKD from 103,485,844 cases of CKD in 2021 to 114,351,930 cases of CKD in 2031, with an AGR of 1.05% during the forecast period. The diagnosed prevalent cases of CKD in the 7MM are expected to increase from 18,135,434 cases in 2021 to 19,917,590 cases in 2030, with an AGR of 0.98% during the forecast period. Women accounted for more total and diagnosed prevalent cases of CKD than men in the 7MM and it predominantly affects older adults. These findings are in line with the GlobalData estimates and these trends are reflected in GlobalData's forecast for the total and diagnosed prevalent cases for the 7MM.
The Chronic Kidney Disease (CKD) Epidemiology series will allow you to -